Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

Systemic antitumor treatment with or without pressurized intraperitoneal aerosol chemotherapy (PIPAC) for colon peritoneal metastases – a mu… Recruiting

2024-514560-10-00 Patients with newly diagnosed advanced peritoneal metas 4 2025-06-12
A phase 3 multicenter, randomised, prospective, open-label trial of fixed-duration (12 cycles) venetoclax/ obinutuzumab vs. fixed-duration (… Recruiting

2023-510294-34-00 small lymphocytic lymphoma (SLL) 5 2025-06-12
Study of Adagrasib plus Pembrolizumab plus Chemotherapy vs. Placebo plus Pembrolizumab plus Chemotherapy in Participants with Previously Unt… Recruiting

2024-515698-85-00 Locally Advanced or Metastatic Non-small Cell Lung Canc 5 2025-06-12
A phase I study to evaluate the safety and preliminary signs of efficacy of [177Lu]Lu-OncoFAP-23 alone and in combination with L19-IL2 as a … Recruiting

2023-509453-31-00 Patients with advanced/metastatic FAP-positive tumors 1 2025-06-11
A clinical study to assess the safety and efficacy of oral ART0380 as a single agent or in combination in solid tumors Recruiting

2024-511534-12-00 Advanced or Metastatic Solid Tumours 7 2025-06-10
SWE-NEO: Swedish NeoAdjuvant Trial Comparing anti-PD-1 Monotherapy to Combined anti-CTLA-4/anti-PD-1 blockade in Resectable Stage III Melano… Recruiting

2024-519593-39-00 Malignant melanoma stage III 5 2025-06-10
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Smal… Recruiting

2024-512302-25-00 Resected or Unresectable KRAS G12C-mutant Non-Small Cel 5 2025-06-06
A clinical study of V940 and BCG in people with bladder cancer (V940-011) Recruiting

2024-517335-46-00 Bladder cancer 4 2025-06-05
A phase I/II trial of ABTL0812 in children with relapsed/refractory neuroblastoma and other solid tumours Recruiting

2023-504246-64-02 Relapsed/refractory neuroblastoma and other solid tumou 9 2025-06-04
Daratumumab in Monoclonal Gammopathy of Renal Significance in Finland, DAMOCLES Recruiting

2024-517676-37-01 Monoclonal Gammopathy of Renal Significance (MGRS) 3 2025-06-01
A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid Tumours Recruiting

2024-519184-18-00 Advanced Solid Tumour 7 2025-05-30
An Open-label, Global, Multi-Arm Study to Evaluate the Efficacy and Safety of Relacorilant in Combination with Different Treatment Regimens … Recruiting

2024-517432-21-00 Gynecological Cancers 4 2025-05-30
A Phase 1, First-in-Human, Dose Escalation Study of JNJ-90189892 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neopla… Recruiting

2024-514341-10-00 Relapsed or Refractory Acute Myeloid Leukemia or Relaps 1 2025-05-27
A Phase 1 Study Evaluating the Safety, Tolerability, and Efficacy of BL-B01D1 in Subjects with Metastatic or Unresectable Non-Small Cell Lun… Recruiting

2023-506539-14-00 Oncology 3 2025-05-27
Primary treatment of follicular lymphoma with rituximab-lenalidomide-tafasitamab for high-risk disease and rituximab-lenalidomide with a 1:1… Recruiting

2023-508196-36-00 Follicular lymphoma 4 2025-05-27
A Phase I/II study of GSK5733584 in combination with anti-cancer therapies for advanced solid tumors Recruiting

2024-517147-31-00 Tumours, Gynecological 9 2025-05-23
A clinical study of MK-3120 in people with solid tumors (MK-3120-002) Recruiting

2024-516817-19-00 Advanced/metastatic solid tumor disease 9 2025-05-23
A Phase 3 Study Comparing BMS-986365 versus Investigator’s Choice of Therapy in Participants with Metastatic Castration-resistant Prostate C… Recruiting

2024-517422-25-00 Metastatic Castration-resistant Prostate Cancer (mCRPC) 5 2025-05-22
A clinical phase IV trial to examine cellular and humoral immunity against measles and chickenpox in children and adolescents 0-18 years in … Recruiting

2024-511182-10-01 Pediatric cancer 6 2025-05-22
Phase II clinical trial of chemotherapy + atezolizumab for stage IIIa and IIIb non-small cell lung cancer followed by atezolizumab as adjuva… Recruiting

2024-515984-68-00 Non-small cell lung cancer (NSCLC) 4 2025-05-20
Cetuximab With or Without Paclitaxel After Pembrolizumab-Chemotherapy in Patients with Squamous Cell Carcinoma of the Head and Neck. Recruiting

2024-514953-31-00 Recurrent/Metastatic Squamous Cell Carcinoma of the Hea 4 2025-05-20
Phase 1 Study of Revumenib in Combination with Intensive Chemotherapy in Participants with AML Harboring Alterations in KMT2A/MLL, NPM1, or… Recruiting

2024-514531-18-00 Acute Myeloid Leukemias 3 2025-05-20
A clinical study of zilovertamab vedotin with R-CHP treatment in people with diffuse large B-cell lymphoma (MK-2140-011) Recruiting

2024-515526-89-00 Diffuse Large B-Cell Lymphoma (DLBCL) 4 2025-05-16
Phase II, single arm, multicentre clinical trial to evaluate the activity of encorafenib plus binimetinib followed by Cemiplimab And Fianlim… Recruiting

2024-513375-40-00 Melanoma 4 2025-05-16